Management of metastatic melanoma to the breast with high-dose interleukin-2 and surgical resection.
Komenaka
Ian K
IK
DeRaffele
Gail
G
Hurst-Wicker
Karl S
KS
Kaufman
Howard L
HL
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007376:Interleukin-2 / Q000008:administration & dosage*; D015412:Mastectomy, Segmental; D008545:Melanoma / Q000188:drug therapy / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012074:Remission Induction; D012878:Skin Neoplasms / Q000473:pathology*; D013997:Time Factors
D000970:Antineoplastic Agents; D007376:Interleukin-2